New explortion of 2213-63-0

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Related Products of 2213-63-0. In my other articles, you can also check out more blogs about 2213-63-0

Related Products of 2213-63-0, A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 2213-63-0, Name is 2,3-Dichloroquinoxaline, molecular formula is C8H4Cl2N2. In a Patent£¬once mentioned of 2213-63-0

ARYLAMINE SUBSTUTUTED QUINOXALINE AND THEIR USE AS ANTICANCER DRUGS

The present invention provides new compounds of formula I and II, which have potential of protein phosphatase 2A (PP2A) agonistt, CIP2A inhibitor and SET antagonist. Also provided are treatment methods using the compounds of formula I and II.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Related Products of 2213-63-0. In my other articles, you can also check out more blogs about 2213-63-0

Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1148 | ChemSpider